B Tillenburg
Overview
Explore the profile of B Tillenburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peitz U, Baumann M, Tillenburg B, Borsch G, Stolte M, Malfertheiner P, et al.
Med Klin (Munich)
. 2002 Jan;
96(12):703-7.
PMID: 11785370
Background And Aim: Rapid blood tests for diagnosis of Helicobacter (H.) pylori infection enable to detect antibodies against H. pylori instantly without laboratory equipment. Primary aim: to validate the Helisal...
2.
Labenz J, Tillenburg B, Peitz U, Verdu E, Stolte M, Borsch G, et al.
Gut
. 1997 Jul;
41(1):33-6.
PMID: 9274468
Background: In patients with duodenal ulcer cure of Helicobacter pylori infection resulted in a pronounced decrease in intragastric pH during treatment with omeprazole. Aim: To test the hypothesis that treatment...
3.
Labenz J, Tillenburg B, Peitz U, Borsch G, Idstrom J, Verdu E, et al.
Am J Gastroenterol
. 1997 Apr;
92(4):576-81.
PMID: 9128302
Objective: We have previously shown that, in duodenal ulcer patients, pH control by omeprazole is less pronounced after cure of Helicobacter pylori infection. The present study was designed to test...
4.
Tillenburg B, Siehoff S, Becker T, Peitz U, Borsch G, Labenz J
Z Gastroenterol
. 1997 Mar;
35(3):165-9.
PMID: 9173687
Basic Problem And Objective Of Study: The situation of pretherapeutical antimicrobial drug resistance of Helicobacter pylori has therapeutical implications. For this reason the present study was designed to evaluate the...
5.
Labenz J, Tillenburg B, Weismuller J, Lutke A, Stolte M
Aliment Pharmacol Ther
. 1997 Feb;
11(1):95-100.
PMID: 9042979
Background: Previous studies have shown that one-week triple therapy consisting of omeprazole, clarithromycin and amoxycillin may cure Helicobacter pylori infection in the vast majority of patients. The present study was...
6.
Labenz J, Idstrom J, Tillenburg B, Peitz U, Adamek R, Borsch G
Aliment Pharmacol Ther
. 1997 Feb;
11(1):89-93.
PMID: 9042978
Aim: To test the hypothesis that 1-week low-dose triple therapy for H. pylori is sufficient for relief from dyspeptic symptoms and healing of duodenal ulcers. Methods: Fifty-nine out-patients with duodenal...
7.
Labenz J, Peitz U, Leusing C, Tillenburg B, Blum A, Borsch G
Gut
. 1997 Jan;
40(1):36-41.
PMID: 9155573
Background: In healthy subjects, continuous infusions of high dose ranitidine and omeprazole produce high intragastric pH values. Aim: To test the hypothesis that both drugs also maintain high intragastric pH...
8.
Labenz J, Barsch G, Peitz U, Aygen S, Hennemann O, Tillenburg B, et al.
Digestion
. 1996 Nov;
57(6):391-7.
PMID: 8913700
This prospective study was designed to validate a novel biopsy urease test as well as a simplified 13C-urea breath test for the detection of Helicobacter pylori. In addition, the hypothesis...
9.
Labenz J, Stolte M, Peitz U, Tillenburg B, Becker T, Borsch G
Aliment Pharmacol Ther
. 1996 Apr;
10(2):207-10.
PMID: 8730252
Aim: The present study was designed to evaluate the efficacy and tolerability of 1-week triple therapy regimens for Helicobacter pylori. Methods: In two consecutive series, 120 patients with proven H....
10.
Labenz J, Tillenburg B, Peitz U, Idstrom J, Verdu E, Stolte M, et al.
Gastroenterology
. 1996 Mar;
110(3):725-32.
PMID: 8608881
Background & Aims: Omeprazole is less effective in healthy subjects than in patients with duodenal ulcers. The aim of this study was to determine whether Helicobacter pylori augments the pH-increasing...